Publication: SINGLE DOSE PHENOBARBITONE PREVENTS CONVULSIONS IN CEREBRAL MALARIA
| dc.contributor.author | N. J. White | en_US |
| dc.contributor.author | R. E. Phillips | en_US |
| dc.contributor.author | S. Looareesuwan | en_US |
| dc.contributor.author | P. Chanthavanich | en_US |
| dc.contributor.author | D. A. Warrell | en_US |
| dc.contributor.other | Mahidol University | en_US |
| dc.contributor.other | Nuffield Department of Clinical Medicine | en_US |
| dc.date.accessioned | 2018-06-14T09:08:55Z | |
| dc.date.available | 2018-06-14T09:08:55Z | |
| dc.date.issued | 1988-07-09 | en_US |
| dc.description.abstract | 48 patients over 6 years of age with strictly defined cerebral malaria were randomised to receive either a single intramuscular injection of phenobarbitone (3·5 mg/kg) or placebo in a double-blind, placebo-controlled study. Phenobarbitone significantly reduced the incidence of subsequent convulsions from 54% to 12·5%, without adverse effects. A single intramuscular injection of phenobarbitone is a simple, cheap, and effective method for prevention of convulsions in cerebral malaria. © 1988. | en_US |
| dc.identifier.citation | The Lancet. Vol.332, No.8602 (1988), 64-66 | en_US |
| dc.identifier.doi | 10.1016/S0140-6736(88)90002-5 | en_US |
| dc.identifier.issn | 01406736 | en_US |
| dc.identifier.other | 2-s2.0-0023905618 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/15611 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0023905618&origin=inward | en_US |
| dc.subject | Medicine | en_US |
| dc.title | SINGLE DOSE PHENOBARBITONE PREVENTS CONVULSIONS IN CEREBRAL MALARIA | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0023905618&origin=inward | en_US |